The use and misuse of opioids are a growing global problem. Although the effects of these
drugs on the human endocrine system have been studied for decades, attention on their …

Background Vertebral augmentation, such as vertebroplasty (VP) or kyphoplasty (KP), has
been utilized for decades to treat OVCFs; however, the precise impact of this procedure on …

The purpose of this study was to determine the real-world incidence and predictors of
additional vertebroplasty or balloon kyphoplasty after initial vertebral augmentation, as a …

Objective To retrospectively analyze prognostic factors in osteoporotic patients who treated
with percutaneous vertebroplasty for refracture after vertebral augmentation. Methods A …

Background: Approximately 700,000 individuals experience osteoporotic vertebral
compression fractures (OVCF) every year in the United States. Chronic complications from …

Interventional radiologists now perform spinal interventions routinely for diagnostic and
therapeutic purposes. New technologies for the management of spine pathologies have …

Objective The primary objective of this study was to assess opioid use in the 90 days
following kyphoplasty (KP) compared to the period between compression fracture and KP …

The vertebral compression fracture represents the vertebral body deformity appeared over
lateral spine imageries. In order to evaluate the vertebral compression fracture (VCF), the …

A previous WA-HCA HTA of the same title was published in November 2010, and based on
this, the Committee's Coverage Decision was that VP, KP, and sacroplasty are not covered …

Purpose The number of patients with re-fracture after vertebral augmentation has gradually
increased. Usually, these patients are re-treated with vertebral augmentation, but less …